In this small group, followed for more than 20 years, melanosis was not a precursor of melanoma. One patient, who attended the Vulvar Clinic but was not included in this melanosis study, was found to have co-existing melanosis well away from her melanoma in situ and malignant melanoma at presentation. It was not possible to determine if these findings represented a progression of the benign to malignant. Biopsy of abnormal hyper pigmented vulvar skin is recommended. Current knowledge suggests that vulvar melanosis is a benign condition but to be on the safe side follow up of all hyper pigmented vulval lesions to detect early malignant change is recommended.
INTRODUCTION
Variations in melanin pigmentation of the vulval skin are considerable within and between different races, age and in relation to hormonal status [1] . Causes of hyperpigmentation due to melanin excess include lentigo; melanin incontinence with melanin within macrophages in the upper dermis following inflammation; adult vulval acanthosis nigricans which affects the entire vulva; pseudoacanthosis nigricans of flexural skin in obese and darkish skinned people and following fixed drug eruption. The main concern is distinguishing between benign lesions and malignant melanomas of the vulva. Vulval skin biopsy will distinguish between areas of hyperpigmentation due to melanin, melanoma in situ and malignant melanomas. The macroscopic and histological features of normal vulval skin during life have been described elsewhere [2] .
The aim of this paper is to review the clinical features, look for predisposing factors and determine the long term outcomes for women who presented to the Vulval Disease Clinic at the Royal Brisbane Hospital between 1976 and 1988 with vulvar melanosis and determine if any lesion progressed to a melanoma.
METHODS
All patients presenting to the Vulval Diseases Clinic between 1976 and 1988 had their clinical and pathology details recorded on proforma cards in addition to the hospital records. In 2010 the hospital records were reviewed and the proforma cards up dated. Records were cross checked with the state wide Queensland Centre for Gynaecological Cancer (QCGC) data base to determine if any patient had been lost to follow up and subsequently developed a gynaecological malignancy, especially vulval malignant melanoma.
Data from the up-dated proforma cards were stored and analysed using the computer software Statistical Package for the Social Sciences (SPSS) 11.0.
Ethics approval for the review of case records was obtained from the Clinical Research Ethics Committee of the Royal Brisbane and Women's Hospital.
RESULTS
Of 361 patients seen at the clinic between 1976 and 1988, 12 (all Caucasian) were found to have vulvar melanosis. Patient age at presentation is shown in one patient were parous. Three patients presented with a symptomatic vulvar dystrophy (history of pruritus vulvae for between 3 months and 5 years), one patient presented with pruritus vulvae due to vulval intra epithelial neoplasia (VIN 3) remote from her vulvar melanosis, and one presented with a vaginal discharge. The other patients were referred for review of their vulval pigmentation noted at routine gynaecological examination. The highest incidence of melanosis was found in post menopausal patients (67%), but can occur before this time.
The anatomical location of the vulvar melanosis appeared to "favour" the labia minora (8 cases) and introitus (2 cases). The lesions were of variable size (1 -5 cm), flat and the affected skin had a normal texture. No patients had clinical groin lymphadenopathy. In an attempt to determine if there were any predisposing features for the development of vulvar melanosis coexisting medical conditions were sought. Various conditions were found in 11 patients ( Table 2) , but apart from the possibility of skin irritation associated with the presence of a vulvar dystrophy being a cause rather than an association, no predisposing features were found.
No treatments were used to manage the vulvar melanosis and no patients developed malignant melanoma of the vulva between 25 and 33 years after presenting to the Vulval Diseases Clinic. However, another patient aged 75 who attended the Vulvar Clinic but not included in this melanosis study, was found to have co-existing melanosis well away from her melanoma in situ and malignant melanoma at presentation in 1977.
QCGC data from the beginning of data collection in 1985 to 2009 record 42 patients with vulval melanoma of whom 20 died of their disease and 6 died of unrelated causes. Their ages at diagnosis ranged from 25 to 92 years and this data was compared with the ages of diagnosis for the melanosis cases ( Table 1) . Treatment regimes for the melanoma group included wide local excision; partial vulvectomy; radical vulvectomy and bilateral 
DISCUSSION
The aims of this paper were to determine if vulvar melanosis progressed to melanoma over a period of 20 years or more; review the clinical features; determine if there were any predisposing features for the development of melanoma and determine the long term outcomes for women who presented to the Vulvar Disease Clinic with vulvar melanosis. The need for a long term follow-up study of melanosis was because it is unknown if melanosis could be a forerunner of melanoma, and if it was how long such changes take to occur. Table 1 shows the age distribution for patients presenting with vulval melanosis (36 to 85 years) compared with vulval melanoma (25 to 92 years), which because of advanced age when discovered suggests some patients take a considerable time for a melanoma to develop. Even with a 30 year follow up this may not be long enough for some patients to develop vulvar melanoma. The prevalence of vulval melanosis is unknown. Large melanotic lesions of the vulva are uncommon [3, 4] . A study of 301 new patients presenting to a gynaecology practice over a one year period found 31 (10%) had pigmented lesions on the vulva, six (2%) had diffuse hyper pigmentation of the vulva and seven (2%) had vulval nevocytic nevi [5] .
The most common cause of vulval hyperpigmentation due to melanin (which must be distinguished histolo-gically from haemosiderin), is lentigo [1] . Lentigo, also known as lentigo simplex, is a benign pigmented prolixferation of epidermal or mucous membrane melanocytes which form smooth, non-infiltrating dark brown lesions on the labia minora and introitus. Lentigo is of unknown aetiology and pathogenesis and lesions do not usually exceed one cm in diameter [1] . However, in the current study melanosis varied in size from one to five cm. Sison-Torre & Ackerman [6] described eight women with extensive pigmentation of the vulva and used the term melanosis of the vulva. They showed on biopsy that these lesions were benign and analogous to lentigo. Lentigines may resemble junctional naevi, but do not exhibit cytological atypia [7] . This raises the question could vulvar melanosis be the big sister to lentigo simplex with the difference being size alone?
OPEN ACCESS
Vulval pigmentation depends on the presence of cells containing melanin [8] . The detection of such pigmentation can be obscured by dermal vascularity, the thickness of overlying skin and the position of the melanin containing cells within the skin. The distribution of pigmentation of dark-skinned races is concentrated in the basal layer, but varies considerably in amount. Microscopic patches of melanin pigment were found in almost 80 per cent of 35 Caucasian women at post mortem when there was no evidence of macroscopic hyper pigmentation [8] .
The differential diagnosis of vulval hyperpigmentation is lentigo; junctional naevi; following inflammatory conditions like lichen planus; adult vulval acanthosis nigricans which affect the entire vulva and may be associated with an adenocarcinoma or occasionally lymphoma or epithelial carcinoma; the pseudo-acanthosis nigricans of flexural skin in obese and darkish skinned people (now thought to be related to insulin resistance) and following fixed drug eruption from for example, sulphonamides. The most important risk for these patients is the possibility of misdiagnosing a malignant melanoma. Making a clinical diagnosis based on the anatomical site and skin texture is not foolproof, hence biopsy and histological diagnosis is recommended. Even in the case of the 75 year old woman who presented with co-existing melanosis, melanoma in situ and malignant melanoma, it was not possible to determine if these findings represented a progression from the benign to malignant. The importance of follow up of all hyper pigmented vulval lesions to detect early malignant change is stressed.
Variations in terminology to describe benign hyperpigmentation due to the presence of melanin include vulvar melanosis, idiopathic lenticular mucocutaneous pigmentation and genital lentiginosis [1] . However vulvar melanosis or its other name melanosis vulvae seem to be terms used by the majority when referring to this condition.
CONCLUSION
The difficulty in finding a suitable term for benign hyperpigmentation of vulval skin conditions remains. To reliably diagnose a hyper pigmented vulval lesion a histopathology diagnosis is required. Current knowledge suggests that vulvar melanosis is a benign condition but to be on the safe side follow up of all hyper pigmented vulval lesions to detect early malignant change is recommended.
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